|Bid||76.66 x 0|
|Ask||79.66 x 0|
|Day's range||76.46 - 78.22|
|52-week range||57.80 - 81.04|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||6.27|
|Forward dividend & yield||0.44 (0.57%)|
|Ex-dividend date||02 Jun 2023|
|1y target est||96.80|
EXOR N.V. (AMS: EXO) (“Exor” or the “Company”) announces that, under the third tranche of the share buyback program of up to €150 million announced on 17 April 2023 (the “third tranche”), the Company has completed the following transactions on Euronext Amsterdam and CBOE DXE: EURONEXT AMSTERDAM Trading DateNumber of ordinary shares purchasedAverage price per share excluding fees (€)Total consideration excluding fees (€)15 May 202339,83378.07163,109,826.2016 May 202340,91578.47283,210,714.9417 Ma
Lingotto Investment Management, backed by Italy's Agnelli family, has hired former British finance minister George Osborne and veteran fund manager James Anderson as it weighs expanding its assets under management, it said on Monday. Owned by Exor NV, the Agnelli family holding company, Lingotto, builds on investment activities Exor previously managed on behalf of its former reinsurance unit ParnerRe, which it sold last year to French insurance group Covea.
The Chairman and Senior non-executive director of Exor, Ajay Banga, has submitted his resignation today following his nomination as the next President of the World Bank. As previously announced, Nitin Nohria will be proposed as Exor's new Chairman at the next Annual General Meeting of the Company which will take place on Wednesday 31st May 2023. Exor CEO John Elkann will act as interim Chairman until Mr. Banga's successor is nominated. “I would like to take this opportunity to thank Ajay for the
MILAN (Reuters) -Exor the holding company of Italy's Agnelli family, will seek further opportunities to expand in healthcare after investing almost one billion euros ($1.1 billion) in the industry last year, CEO John Elkann said on Monday. After completing the sale of its reinsurer PartnerRE, Exor has around 6.5 billion euros in cash available for investments, including 5 billion euros for acquisitions. Last year Netherlands-based Exor bought a 10% stake in French healthcare group Institut Merieux for 833 million euros and a 45% stake in Lifenet Healthcare, an Italian company managing hospitals and outpatient clinics, for 67 million euros.
Net cash position up €4.7 billion, at €0.8 billion at year-endNAV at year end at €28.2 billion. NAV per share declined 7.6%, while outperforming the MSCI World Index by 6.6 p.p., mainly driven by the market performance of listed companies and cash positionBoard of Directors nominates for AGM appointment Nitin Nohria as new Chairman, Senior Non-Executive Director and Sandra Dembeck and Tiberto Ruy Brandolini D’Adda as new Non-Executive DirectorsBoard of Directors approved today final €150 million
EXOR N.V. announced today the following Corporate Calendar for 2023: 17 April 2023: Board of Directors to approve the Company’s 2022 Annual Report 31 May 2023: Annual General Meeting of Shareholders to adopt the Company’s 2022 Financial Statements 13 September 2023: Board of Directors to approve the Company’s 2023 Half-year Report The 2023 Corporate Calendar will be available on Exor’s corporate website under the Corporate Calendar section. Any changes will be disclosed to the market on a timely
Exor N.V. (“Exor”) has been informed that Andrea Agnelli, a non-executive director of Exor, will not stand for re-election at this year’s annual general meeting of shareholders (the “2023 AGM”). Andrea Agnelli was re-appointed on 20 May 2020 for a term of three years, which term will expire at the close of the 2023 AGM. Exor expresses its sincere thanks to Andrea Agnelli for his valuable contribution to Exor’s Board of Directors. Attachment Exor Press Release - AA announcement
EXOR N.V. (AMS: EXO) (“Exor”) today starts the process of the implementation of the Board resolution to cancel 7,007,464 ordinary shares or just under 3% of Exor's ordinary issued share capital. These ordinary shares have been acquired as part of the share buyback program which started on 14 November 2018 and completed on 6 November 2020 (for a total of 5,483,361 ordinary shares) and the first tranche of the share buyback program which started on 8 March 2022 and completed on 20 June 2022 (for a
EXOR N.V. (AMS: EXO) (“Exor”) has been selected for inclusion in the AEX Index after its listing on Euronext Amsterdam on 12 August 2022. This was announced by Euronext Amsterdam today following its December quarterly review. Exor will start trading as part of the AEX Index effective 19 December 2022.The AEX is a leading European index that reflects the performance of the 25 largest companies listed in the Netherlands based on free-float adjusted market capitalization, and is the most widely use
MILAN (Reuters) -Exor, the holding company of Italy's Agnelli family, has around 6.5 billion euros ($6.7 billion) in cash available for investments, including 5 billion euros for acquisitions, Chief Executive Officer John Elkann said on Wednesday. But Elkann, the scion of the Agnelli family - the founders of carmaker Fiat now part of the Stellantis group - played down speculation that Exor was interested in buying Italian fashion group Giorgio Armani. "Giorgio Armani is a company for which we have huge respect," he said.
Exor (“Exor” or the “Company”) will hold today its 2022 Investor and Analyst Call in virtual mode, hosted by Exor’s CEO John Elkann together with the Company’s leadership team. The event will start at 4:00pm CET / 3:00pm GMT / 10:00am EST and will be accessible live both via listen-only webcast and audio conference. Details for accessing the event are available under the Investors & Media - Presentations section of Exor’s website or at the following link. Please note that registration is require
With reference to the decisions taken yesterday by the Board of Directors of Juventus FC and in advance of its Shareholders Meeting called for 18 January 2023, Exor communicates that it will indicate Gianluca Ferrero for the role of Chairman of Juventus. As a corporate adviser, auditor, Board and committee member of a number of companies, Mr. Ferrero has significant experience and the required technical competencies, as well as a genuine passion for the bianconero club, making him the person mos
Exor (“Exor” or “the Company”) the diversified holding company controlled by the Agnelli family, announces three senior appointments and the reorganisation of its investment activities. Suzanne Heywood has been promoted to the newly created role of Chief Operating Officer in which she will deploy her deep, accumulated knowledge of Exor, working closely with Chief Executive Officer John Elkann, with its existing companies and seeking out new ones. Following the completion of the sale of PartnerRe
Amsterdam, Sept. 27, 2022 (GLOBE NEWSWIRE) -- Further to the announcements by Exor (“Exor” or the “Company”) on 12 August and 12 September, the Company hereby announces that the delisting of its ordinary shares (ISIN NL0012059018) from Euronext Milan is effective as of the date hereof, as determined by Borsa Italiana on 12 August. Starting from the date hereof, Exor’s ordinary shares will continue to be listed solely on Euronext Amsterdam. Attachment Exor_PR_Delisting_EuronextMilan